home | molmed
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
Meeting agenda | molmed
MolMed lascia Piazza Affari dopo Opa di Agc - Borse.it
Half-Year Financial Report at June 30th, 2020
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
MolMed now part of AGC Biologics | LinkedIn
MolMed now part of AGC Biologics | LinkedIn
MolMed non vuole il golden power: «Offerta Agc conveniente per tutti» - Il Sole 24 ORE
Prezzi da saldo a Piazza Affari, rischio Opa straniere. Giapponesi su MolMed
MolMed - Wikipedia
Relazione sulla Remunerazione MolMed S.p.A.
Will MolMed soon have its first Cell therapy on the Market?
Relazione sulla remunerazione Molecular Medicine S.p.A.
MolMed to test the health of the European sector | Evaluate
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
COVID-19 impacting Cell&Gene therapy manufacturing Webinar | molmed
MolMed festeggia in Borsa: Germania conferma rimborsabilità Zalmoxis®
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Molmed: Opa giapponese, ok da Fininvest, rally in Borsa - FIRSTonline
Will MolMed soon have its first Cell therapy on the Market?
home | molmed
